Dren Bio, a privately held, clinical-stage biotechnology company, has a new collaboration with Sanofi SA (NASDAQ:SNY). The new agreement is built on the existing relationship between the two companies, following Sanofi’s acquisition earlier this year of Dren Bio’s DR-0201 program for deep B-cell ... Read more
Benzinga - Dec 15
"She was the glue holding this house together," her husband said. Read more
Newsday - Dec 02
LOWELL — On the outside Jack Linehan appears to be like any other kid his age. Up until two years ago, the nine-year-old with long, dirty blonde locks who often sports backwards baseball caps was the happiest, sweetest, and funniest youngster you would ever meet. “Jack knows he’s sick and wants t... Read more
Lowellsun - Nov 16
PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) unveiled promising clinical data from its RESET-MyositisTM, RESET-SScTM, and RESET-SLETM trials evaluating rese-cel (resecabtagene autoleucel), reinforcing its potential to deliver long-lasting, drug-free ... Read more
Mychesco - Nov 06
She is speaking publicly about it for the first time Read more
Express - Aug 13
